The NHS needs to embrace technology for the management of
medication and supplies throughout hospitals if it wants to realise
the cost savings detailed in the recent Lord Carter report, and meet
GS1 standards. Lord Carter’s report highlighted that in 2012/13,
expenditure on hospital medicines showed a staggering 11%
increase on the previous year, to £6.5 bn. Lord Carter believes that
there are greater savings to be had by managing the demand for
medicines via better inventory management systems. He went on
to state that all trusts should have key digital information systems
in place, fully integrated and utilised by October 2018. Paul
O’Hanlon, Managing Director at Omnicell Ltd, UK & Ireland,
shares his thoughts on the NHS.
https://international-pharma.com/wp-content/uploads/2016/07/Reg-1-The-NHS-Must-Invest.pdf